Glaukos Corporation
COMPOUNDS FOR THE TREATMENT OF OCULAR DISEASE

Last updated:

Abstract:

Disclosed herein are compounds for the treatment of ocular diseases and the preparation and use thereof. Some implementations relate to amine and sulfonamide derivatives and their use as therapeutic agents for the treatment of glaucoma.

Status:
Application
Type:

Utility

Filling date:

21 Feb 2020

Issue date:

21 Apr 2022